News

Shares of stock-index compiler MSCI tumbled after earnings. The company’s top executive bought $6.7 million of shares.
Franklin Templeton’s ClearBridge International Value Fund beat its benchmark in Q2 2025. See how smart stock picks and global ...
On Wall Street the Dow Jones Industrial Average fell 171.71 points, or 0.38%, to 44,461.28, the S&P 500 fell 7.96 points, or ...
Vinod Nair, Head of Research, Geojit Financial Services, sheds light on the Indian stock market, focusing on why India has ...
MSCI's Q2 shows mixed results with undervalued shares and strong growth potential in Index & Analytics. Read here for more ...
Q2 2025 Earnings Call Transcript July 22, 2025 MSCI Inc. beats earnings expectations. Reported EPS is $4.17, expectations ...
Index provider MSCI reported a rise in second-quarter profit on Tuesday, as improved spending by clients drove up demand for ...
Experts believe that a stabilizing dollar index could weigh on foreign inflows into emerging markets like India, implying ...
Can investors buy at the current Vanguard MSCI Index International Shares ETF (ASX: VGS) unit price for appealing passive ...
MSCI Inc. (NYSE:MSCI) announced its fiscal 2025 second-quarter results on Tuesday. The company’s total revenue reached $772.7 ...
Buying $100 In MSCI: If an investor had bought $100 of MSCI stock 15 years ago, it would be worth $1,674.60 today based on a price of $559.15 for MSCI at the time of writing.
GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG rating has been upgraded to AA from A by MSCI in ...